Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,034 | -31,062 | -30,430 | -5,663 | -9,705 |
| Depreciation Amortization | 44 | 49 | 217 | 584 | 37 |
| Income taxes - deferred | N/A | N/A | N/A | -9,500 | N/A |
| Accounts payable and accrued liabilities | 273 | 1,696 | -1,364 | -3,196 | 314 |
| Other Working Capital | 965 | 2,096 | -2,314 | -3,618 | 399 |
| Other Operating Activity | 1,657 | 598 | 4,243 | -1,604 | -135 |
| Operating Cash Flow | $-31,095 | $-26,623 | $-29,648 | $-22,997 | $-9,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -21 | -30 | 32,470 | -2 |
| Net Acquisitions | N/A | N/A | N/A | 84,179 | N/A |
| Purchase Of Investment | -7,378 | -11,337 | N/A | N/A | N/A |
| Sale Of Investment | 18,120 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 26,000 | 0 | 0 |
| Investing Cash Flow | $10,742 | $-11,358 | $25,970 | $116,649 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -27 | N/A |
| Common Stock Issued | 35 | 89 | 70 | 140 | 22 |
| Common Stock Repurchased | -1,310 | -675 | N/A | N/A | N/A |
| Other Financing Activity | 699 | -235 | -262 | -38 | 0 |
| Financing Cash Flow | $-576 | $-821 | $-192 | $75 | $22 |
| Beginning Cash Position | 56,007 | 94,809 | 98,679 | 4,952 | 14,022 |
| End Cash Position | 35,078 | 56,007 | 94,809 | 98,679 | 4,952 |
| Net Cash Flow | $-20,929 | $-38,802 | $-3,870 | $93,727 | $-9,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,095 | -26,623 | -29,648 | -22,997 | -9,090 |
| Capital Expenditure | N/A | -21 | -30 | -30 | -2 |
| Free Cash Flow | -31,095 | -26,644 | -29,678 | -23,027 | -9,092 |